Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs…
CHICAGO, IL / ACCESSWIRE / September 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…
Prof. Carl Wittwer Appointed in inbiome's Advisory Board Amsterdam, The Netherlands, September 20, 2024. Inbiome, a pioneer in advanced molecular diagnostics,…
Initial funding of USD 29 million to support development of Basilea’s clinical stage first-in-class antifungals, fosmanogepix and BAL2062Multi-year Other Transaction…
The Nanocoatings market is driven by increasing demand across industries like automotive, electronics, and healthcare, where the coatings' enhanced durability,…
HALIFAX, Nova Scotia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”),…
Exclusive partnership brings Verily’s innovative wastewater surveillance technology to the United Kingdom DALLAS--(BUSINESS WIRE)--Today, Verily, a precision health technology company,…
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / Dental implants are one of the most expensive procedures, but…
Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and…
RESTON, Va., Sept. 3, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN)…